Infection and inflammation in cystic fibrosis: a short review
- PMID: 15970469
- DOI: 10.1016/j.jcf.2005.05.005
Infection and inflammation in cystic fibrosis: a short review
Abstract
In most patients with cystic fibrosis (CF) life expectancy is limited due to a progressive loss of functional lung tissue. Already very early in life a persistent neutrophylic inflammation can be demonstrated in the airways. The cause of this inflammation, the role of CFTR and different CF specific bacteria like Pseudomonas aeruginosa are not well understood. This short review summarises the current understanding and hypothesis of the origin of this complicated process of inflammation and infection. Better understanding of this process may lead to the development of new treatment modalities of CF lung disease and consequent improvement of life expectancy.
Similar articles
-
Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies.Lab Anim. 2008 Oct;42(4):389-412. doi: 10.1258/la.2007.06014e. Epub 2008 Sep 9. Lab Anim. 2008. PMID: 18782827 Review.
-
Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens.Nat Genet. 1995 Apr;9(4):351-7. doi: 10.1038/ng0495-351. Nat Genet. 1995. PMID: 7540910
-
Challenging and emerging pathogens in cystic fibrosis.Paediatr Respir Rev. 2010 Dec;11(4):246-54. doi: 10.1016/j.prrv.2010.07.003. Epub 2010 Aug 7. Paediatr Respir Rev. 2010. PMID: 21109184 Review.
-
Cytokines and inflammatory mediators in cystic fibrosis.J Cyst Fibros. 2004 Dec;3(4):223-31. doi: 10.1016/j.jcf.2004.06.006. J Cyst Fibros. 2004. PMID: 15698939 Review.
-
Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.Mol Microbiol. 2005 Apr;56(2):309-22. doi: 10.1111/j.1365-2958.2005.04552.x. Mol Microbiol. 2005. PMID: 15813726 Review.
Cited by
-
Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis.BMC Infect Dis. 2015 Jul 27;15:290. doi: 10.1186/s12879-015-1019-4. BMC Infect Dis. 2015. PMID: 26212271 Free PMC article.
-
Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.J Antimicrob Chemother. 2015 Jan;70(1):160-6. doi: 10.1093/jac/dku357. Epub 2014 Sep 11. J Antimicrob Chemother. 2015. PMID: 25213272 Free PMC article.
-
MLN4924 protects against bleomycin-induced pulmonary fibrosis by inhibiting the early inflammatory process.Am J Transl Res. 2017 Apr 15;9(4):1810-1821. eCollection 2017. Am J Transl Res. 2017. PMID: 28469786 Free PMC article.
-
Impact of enzymatic digestion on bacterial community composition in CF airway samples.PeerJ. 2017 May 30;5:e3362. doi: 10.7717/peerj.3362. eCollection 2017. PeerJ. 2017. PMID: 28584706 Free PMC article.
-
Govaniadine Ameliorates Oxidative Stress, Inflammation, and Kupffer Cell Activation in Carbon Tetrachloride-Induced Hepatotoxicity in Rats.ACS Omega. 2021 Jan 21;6(4):2462-2472. doi: 10.1021/acsomega.0c02261. eCollection 2021 Feb 2. ACS Omega. 2021. PMID: 33553864 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical